Press release content from Accesswire. The AP news staff was not involved in its creation.
The Economist invites Victor Ai to elaborate on the AI CITY
March 10, 2021 GMT
BEIJING, CHINA / ACCESSWIRE / March 10, 2021 / The Economist’s virtual event “Technology for Change Week Asia” took place this week between 8th-12th of March. With over 40 hours of content, more than 100 speakers from around the globe joined the event, once again bringing Asia into the spotlight of urban digitization. Terminus Group’s Founder and CEO, Victor Ai, was invited to give a speech on Terminus AI CITY during the case studies session on the second day of the event.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Gungnir Announces 2021 Work Plans in Sweden
March 10, 2021 GMT
SURREY, BC / ACCESSWIRE / March 10, 2021 / Gungnir Resources Inc. (TSXV:GUG)(OTC PINK:ASWRF) (“Gungnir” or the “Company”) announces drilling and geophysical work plans at the Company’s gold and nickel-copper-cobalt-PGE projects in northern Sweden.
Work Plans:
Drilling to test structural extensions of the Knaften 300 Gold Zone “Knaften 300”. Drill results at Knaften 300 include shallow intersections of high-grade gold (59.6 g/t Au over 1.00 metres in hole KN19-06) and numerous wide zones of gold mineralization including 2.92 g/t Au over 13.00 m metres in hole 200707 (re-sample by Gungnir);
Press release content from Business Wire. The AP news staff was not involved in its creation.
AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19
March 10, 2021 GMT
VANCOUVER, British Columbia (BUSINESS WIRE) Mar 10, 2021
AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly and Company (Lilly), and etesevimab 1400 mg (LY-CoV16) together reduced COVID-19-related hospitalizations and deaths by 87% in high-risk patients recently diagnosed with COVID-19. These results mark the second positive Phase 3 trial readout for bamlanivimab and etesevimab together, adding to the growing safety and efficacy data that has resulted in the following key milestones accelerating the adoption of the antibody therapy globally:
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
VERB Partners with Vlad Kachur, Top Social Media Influencer for Small Businesses and .
Verb Technology Company, Inc.March 10, 2021 GMT
Partnership expected to increase awareness of
, a powerful livestream ecommerce sales and marketing tool for small businesses, retailers, and entrepreneurs to drive customer engagement and sales productivity
VERB recently made verbTEAMS available for free to support SMBs and solo entrepreneurs in current difficult pandemic-related selling environment
NEWPORT BEACH, Calif. and SALT LAKE CITY, March 10, 2021 (GLOBE NEWSWIRE) Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), a rapidly emerging market leader in business-focused interactive video sales and marketing tools, including livestream ecommerce, CRM, and content management applications, today announced that it has partnered with leading social media influencer Vlad K